3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Glioblastoma
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Renal Insufficiency
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Melanoma
1
Lung Neoplasms
1
Liver Failure
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Specimen Handling
4
Cyclophosphamide
4
Biopsy
4
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
sodium-iodide symporter
2
pembrolizumab
2
mogamulizumab
2
fludarabine phosphate
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Busulfan
2
Brentuximab Vedotin
2
talimogene laherparepvec
1
ruxolitinib
1
hypericin
1
duvelisib
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
veliparib
×
90 days
×
Clear all
No trials found.